0001776707-21-000001.txt : 20210809 0001776707-21-000001.hdr.sgml : 20210809 20210806190640 ACCESSION NUMBER: 0001776707-21-000001 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b ITEM INFORMATION: Investment Company Act Section 3(c) ITEM INFORMATION: Section 3(c)(1) FILED AS OF DATE: 20210809 DATE AS OF CHANGE: 20210806 EFFECTIVENESS DATE: 20210809 FILER: COMPANY DATA: COMPANY CONFORMED NAME: RS2 Ventures, LP - MD Series A CENTRAL INDEX KEY: 0001776707 IRS NUMBER: 834529738 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-340449 FILM NUMBER: 211154214 BUSINESS ADDRESS: STREET 1: 3953 MAPLE AVENUE STREET 2: SUITE 180 CITY: DALLAS STATE: TX ZIP: 75219 BUSINESS PHONE: 2148718682 MAIL ADDRESS: STREET 1: 3953 MAPLE AVENUE STREET 2: SUITE 180 CITY: DALLAS STATE: TX ZIP: 75219 D/A 1 primary_doc.xml X0708 D/A LIVE 0001776707 RS2 Ventures, LP - MD Series A 3953 MAPLE AVENUE SUITE 180 DALLAS TX TEXAS 75219 2148718682 DELAWARE None None Limited Partnership true 2019 N/A RS2 Ventures GP, LP 3953 Maple Avenue Suite 180 Dallas TX TEXAS 75219 Director Promoter General Partner of the Issuer N/A RR Advisors, LLC 3953 Maple Avenue Suite 180 Dallas TX TEXAS 75219 Director Promoter General Partner and Investment Advisor of the Issuer's General Partner Robert Raymond 3953 Maple Avenue Suite 180 Dallas TX TEXAS 75219 Executive Officer Managing Member of the General Partner to the Issuer's General Partner Sean Maher 4306 Yoakum Blvd. Suite 530 Houston TX TEXAS 77006 Executive Officer Assistant Secretary of the General Partner to the Issuer's General Partner Tonya A Hamilton 3953 Maple Avenue Suite 180 Dallas TX TEXAS 75219 Executive Officer Assistant Secretary of the General Partner to the Issuer's General Partner Pooled Investment Fund Private Equity Fund false Decline to Disclose 06b 3C 3C.1 true 0001837365-21-000001 2019-05-10 false true false 50000 41605296 41605296 0 false 54 0 0 189389 true The General Partner is entitled to a performance allocation. The investment manager is entitled to a management fee. The performance allocation and management fee are fully discussed in the Issuer's confidential offering materials. false RS2 Ventures, LP - MD Series A Erin Rosenthal Erin Rosenthal Attorney-in-Fact of the Issuer 2021-08-06